Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.
Blood
; 121(1): 136-47, 2013 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-23165478
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thionucleotides
/
Vidarabine
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Oligonucleotides, Antisense
/
Nanoparticles
/
Antibodies, Monoclonal, Murine-Derived
/
Molecular Targeted Therapy
/
Antimetabolites, Antineoplastic
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood
Year:
2013
Type:
Article
Affiliation country:
United States